alkalma and BeehiveX leadership have signed a Memorandum of Understanding (MoU) to explore ways to help people take a more active role in their health, combining evidence-based healthcare programmes with behavioural science and community engagement.

The collaboration will focus on what helps or prevents people from acting on health advice, and how programmes can better support participation in screening, earlier support-seeking, and healthier behaviours. It will initially focus on the UAE, with opportunities elsewhere in the region considered jointly.

alkalma provides mental health and wellbeing services based on Keralty’s Population Health Management expertise to identify the health needs and risks of different population groups and implement health programmes to improve prevention, early detection and coordinated care. BeehiveX contributes behavioural science, research, and communication expertise to understand people’s motivations, the barriers they face, and their readiness to change.

Together, the organisations aim to connect health programme design with a deeper understanding of how people engage with them. Potential areas of collaboration include community wellbeing initiatives, school and workplace programmes, and support for people managing long-term health conditions. The partnership will also explore opportunities to jointly design, pilot and evaluate innovative behavioural interventions, generating evidence of what works and supporting the development of more effective, scalable health programmes.

Dr Emilio Herrera, CEO of alkalma and Keralty MENA, said: “A health programme needs to do more than identify a risk or explain what someone should do. It also needs to understand their circumstances and help them take the next step. By combining our Population Health Management  expertise with BeehiveX’s understanding of behaviour, we aim to develop approaches that make prevention and early support more relevant to people’s everyday lives. Our focus is on meaningful progress in health and wellbeing.”

Dr Omar Najim, Chairman, BeehiveX, said: “Awareness alone does not change behaviour. Real impact comes from understanding people, removing barriers to action and making healthier choices easier. By combining BeehiveX’s expertise in behavioural science, human-centred design and technology with alkalma and Keralty MENA’s Population Health Management capabilities, we aim to move beyond conventional awareness campaigns towards innovative, evidence-based interventions that create measurable and lasting improvements in health and wellbeing.”

The MoU was signed at Future Health in Abu Dhabi. Specific initiatives will be developed and agreed jointly by the two organisations.

The post alkalma And BeehiveX Partner To Transform Health Awareness Into Preventive Action appeared first on Abu Dhabi Healthcare Guide.

PureHealth announced the acquisition of six clinic facilities from Aspen Clinics, marking a further step in strengthening its community healthcare network across Abu Dhabi and Al Ain. Upon completion, the clinics will be integrated into SEHA CLINICS, further strengthening PureHealth’s role in advancing Abu Dhabi’s healthcare ecosystem and reinforcing its commitment to accessible, high-quality care across the UAE.

Shaista Asif, Group Chief Executive Officer of PureHealth, said: “This acquisition reflects PureHealth’s long-term commitment to strengthening healthcare delivery across the UAE. By expanding our community-based infrastructure in Abu Dhabi and Al Ain, we are enhancing access to care, reinforcing clinical capacity, and supporting a more resilient, integrated healthcare system that delivers meaningful impact for patients and communities.”

The facilities are located in Shakhbout City, Al Wathba, Al Salamat, Abu Samrah, Al Dhahirah, and Um Ghafah, expanding coverage across residential areas and supporting the emirate’s evolving community healthcare needs.

This expansion aligns with PureHealth’s broader growth strategy in the UAE, focused on targeted investment in healthcare infrastructure, strengthening clinical networks, and supporting Abu Dhabi’s vision to advance health outcomes through accessible, integrated, and patient-centric care. The clinics are expected to deliver a range of outpatient and community-based healthcare services, aligned with SEHA CLINICS’ care model and local community requirements.

The post PureHealth Acquires 6 Facilities From Aspen Clinics, Strengthening Community Healthcare Network Across Abu Dhabi And Al Ain appeared first on Abu Dhabi Healthcare Guide.

Cleveland Clinic Abu Dhabi is offering an advanced food intolerance test using endomicroscopy for the first time in the Middle East and North Africa. Approved by the Department of Health – Abu Dhabi, the technology allows doctors to see how intestinal cells respond to specific foods in real time during the examination, helping them identify foods the patient may not tolerate, to provide personalized dietary recommendations, and develop care plans tailored to each patient’s long-term needs.

The Department of Health – Abu Dhabi’s approval of the technology forms part of its efforts to support the use of advanced medical technologies, helping advance diagnostic methods and improve the quality of patient care.

During the examination, small amounts of food particles are introduced directly into the small intestine. Doctors use an endoscope equipped with microscopic imaging technology to observe how intestinal cells respond to these foods. The procedure is performed under sedation and typically takes less than an hour.

The test involves an upper gastrointestinal endoscopy and is intended for patients experiencing chronic food-related symptoms, such as persistent bloating, diarrhea, abdominal pain, and digestive discomfort, based on a specialist’s assessment.

Dr. Sacha Sidani, Staff Physician, Gastroenterology, Digestive Disease Institute, Cleveland Clinic Abu Dhabi said, “Many patients with chronic gastrointestinal symptoms spend years searching for answers. This technology allows us to see what happens at a cellular level in the intestines, giving us a level of diagnostic precision that was not previously possible. By identifying the exact foods triggering the patient’s symptoms, we can provide personalized, effective care to significantly improve their quality of life.”

Persistent discomfort and uncertainty about their causes can lead some patients to exclude broad groups of foods without medical guidance, potentially affecting their nutritional balance. This advanced test complements conventional food allergy tests by providing additional information that may help identify underlying causes that have remained unexplained for years in some patients. It enables more targeted, evidence-based dietary management, helps reduce unnecessary restrictions, and supports more personalized care planning.

The medical team determines whether the test is suitable for each patient and provides preparation and recovery instructions tailored to their condition. To prepare, patients are required to follow a specialized hypoallergenic diet for two weeks and fast for eight hours prior to the test. Recovery is typically rapid, with most patients able to resume eating within an hour and return to normal activities the following day.

Recognized by Newsweek in its inaugural Best Specialized Hospitals Middle East 2026 rankings as the top hospital for gastroenterology in the region, Cleveland Clinic Abu Dhabi continues to advance precision medicine and advanced diagnostics, offering new clarity for patients with chronic, unexplained gastrointestinal symptoms, while reinforcing Abu Dhabi’s growing role in shaping the future of specialized healthcare. 

The post Cleveland Clinic Abu Dhabi Offers Advanced Food Intolerance Test For The First Time In The Middle East And North Africa appeared first on Abu Dhabi Healthcare Guide.

SEHA, a subsidiary of PureHealth, the largest healthcare group in the Middle East, has launched a year-round women’s awareness campaign through SEHA’s Blood Bank Services to recognise women’s contribution to voluntary blood donation and encourage more eligible women to become regular donors, supporting patients and strengthening community wellbeing across the UAE.

Designed as an ongoing platform rather than a single-occasion initiative, the campaign brings together women-focused awareness activities, educational outreach, community engagement and donor recognition programmes throughout the year. Through these efforts, SEHA Blood Bank Services aims to increase understanding of voluntary blood donation and encourage sustained participation among eligible women.

Women continue to make an important contribution to maintaining a safe and sustainable blood supply. Since 2020, 8,599 Emirati women have registered as blood donors, contributing 5,174 successful donations, which reflects their growing participation in voluntary blood donation and humanitarian giving.

The campaign also aligns with the UAE’s wider commitment to empowering women and strengthening community health by creating opportunities for females to contribute directly to the wellbeing of patients and communities.

Dr. Eiman Al Zaabi, Medical Director, SEHA’s Blood Bank Services, said: “Women have made an important and growing contribution to voluntary blood donation, and this campaign provides an opportunity to recognise that contribution while encouraging more eligible women to take part. By maintaining engagement throughout the year through education, awareness, and recognition, we aim to support regular donation and strengthen a culture of community responsibility.”

Through the campaign, SEHA’s Blood Bank Services will continue working with community organisations, educational institutions, corporate partners, and women’s associations to expand awareness and engagement around voluntary blood donations.

The year-round initiative reinforces SEHA’s Blood Bank Services’ commitment to supporting a safe and sustainable blood supply while recognising the important role individuals and communities can play in helping meet patients’ ongoing blood needs.

The post SEHA Blood Bank Services Launches Year-Round Campaign Celebrating Women’s Contribution To Blood Donation appeared first on Abu Dhabi Healthcare Guide.

SEHA, a subsidiary of PureHealth, the largest healthcare group in the Middle East, has announced that a woman with type 1 diabetes and severe endometriosis achieved pregnancy following a personalised treatment plan provided by the fertility services team at SEHA Tawam Hospital. Both conditions may affect fertility and the likelihood of conception. The evidence-based approach used assisted reproductive techniques tailored to her medical needs.

The patient had experienced primary infertility for two years and had advanced endometriosis without apparent symptoms. Endometriosis occurs when tissue similar to the lining of the uterus grows outside it and may affect the reproductive organs. Tests showed adhesions involving both ovaries and bilateral ovarian cysts associated with endometriosis. They also showed a satisfactory ovarian reserve, and both fallopian tubes were open.

Given the complexity of the case, the team followed a treatment approach focused on preserving ovarian reserve and avoiding unnecessary surgery, in line with clinical evidence. The patient underwent a treatment cycle using intracytoplasmic sperm injection (ICSI) as part of a personalised plan, and suitable embryos were preserved for use at a later stage of treatment.

Tests also identified subclinical hypothyroidism, which was managed with low-dose thyroxine. She then underwent a personalised embryo transfer cycle based on her medical history and the outcomes of previous treatment cycles, which resulted in a successful pregnancy.

Dr. Meenakshi Khetaram Choudhary, Consultant IVF Physician at SEHA Tawam Hospital, said: “Endometriosis can be invisible and painless, and its severity does not always correlate with symptoms. Our role is to recognise it early, protect ovarian reserve, and tailor IVF strategies to each woman’s biology and medical context, especially in high-risk scenarios such as Type 1 diabetes.”

Dr. Choudhary added: “Continuity of care after conception is essential. Our obstetric and endocrine teams work closely together to ensure women with complex needs experience a coordinated journey from fertility treatment to a safe, supported pregnancy.”

The patient is now under synchronised high-risk antenatal care within SEHA Tawam Hospital multidisciplinary framework, with ongoing endocrine optimisation and obstetric surveillance. Several remaining embryos are stored for potential future family planning.

SEHA Tawam Hospital provides comprehensive reproductive medicine services, including diagnostics, IVF and ICSI, and fertility preservation, as well as coordinated high-risk antenatal management. The centre is committed to delivering compassionate, evidence-based, patient-centred care grounded in ethical principles and supported by an experienced multidisciplinary team.

The post SEHA Tawam Hospital’s Fertility Services Support Successful Pregnancy In Complex Case Involving Type 1 Diabetes And Severe Endometriosis appeared first on Abu Dhabi Healthcare Guide.

Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the UAE for serious and complex care and a subsidiary of PureHealth, the largest healthcare group in the Middle East, participated in the Annual Pink Drive 2026 at Tilal Sweihan, organised by Wiredin and UAE OffRoader alongside the Emirates Oncology and Radiotherapy Association (EORA).

SSMC’s participation reinforced the importance of early detection, informed healthcare decisions and continued support for individuals and families affected by breast cancer. Recently ranked No. 1 in Abu Dhabi and No. 2 in the UAE for oncology in Newsweek’s World’s Best Specialized Hospitals 2027, SSMC continues to build on its clinical expertise to deliver specialised cancer care that meets the needs of patients and their families.

Dr Aisha Alsalami, Consultant Medical Oncologist, represented SSMC at the event, drawing on her experience in breast cancer care and survivorship. Her involvement highlighted the importance of supporting patients beyond diagnosis and treatment, recognising that breast cancer affects not only the patient but also their loved ones. Through its focus on clinical care, research, and medical education, SSMC also contributes to advancing cancer care in the UAE.

Held under the theme ‘One Team. One Family. One Cause.’, the activation brought together 200+ attendees, including healthcare professionals, breast cancer survivors and families. Through educational sessions, a dedicated survivor circle and activities including a car decorating competition and a collective pink ribbon formation, the event encouraged open conversations about breast health, celebrated survivors and brought the community together in a show of solidarity.

Taking place during Breast Cancer Awareness Month, SSMC’s participation in the Annual Pink Drive reflected its commitment to making a meaningful difference beyond the hospital. By combining its recognised oncology expertise with community awareness and survivor support, SSMC continues to champion early detection and a more informed, supported cancer journey for patients and their families.

The post SSMC Champions Early Detection And Survivor Support At Annual Pink Drive 2026 appeared first on Abu Dhabi Healthcare Guide.

Reem Hospital, a multispecialty healthcare provider on Abu Dhabi’s Reem Island, has signed a Memorandum of Understanding (MoU) with Yas Clinic Khalifa City during the Future Health Summit in Abu Dhabi, establishing a framework for cooperation across specialized clinical services, physician expertise, medical innovation, and professional development.

The agreement reflects both organizations’ commitment to advancing specialized healthcare and supporting medical innovation through collaboration. By bringing together complementary clinical expertise, Reem Hospital and Yas Clinic Khalifa City aim to explore opportunities to enhance patient care and contribute to the continued development of Abu Dhabi’s healthcare ecosystem. The partnership aligns with the emirate’s broader ambitions to advance healthcare innovation and improve patient outcomes.

Under the MoU, the two organizations will explore cooperation across three clinical areas, namely orthopedics, neuroscience, and dermatology, with a focus on regenerative medicine and cell therapy applications. The scope also covers clinical knowledge exchange, joint case discussions, sharing of physician expertise, professional training, and the development of coordinated patient care pathways between the two entities.

In regenerative medicine and cell therapy, the parties will assess potential clinical service models, research initiatives, and specialized training opportunities. Any activities in these areas will be subject to the required regulatory approvals and separate agreements.

Alaa Obeid, Chief Executive Officer at Reem Hospital, said, “This collaboration gives us a structured way to combine expertise, exchange knowledge, and explore new approaches to specialized healthcare. By working closely with Yas Clinic, we aim to identify opportunities that support clinical advancement and contribute to the continued development of high-quality medical services in Abu Dhabi.”

Mubasher Maqbool, Chief Executive Officer at Yas Clinic Khalifa City, said: “The future of healthcare depends on strong collaboration between providers, bringing together complementary expertise to advance specialized care and improve patient outcomes. Through this partnership with Reem Hospital, we look forward to exploring opportunities for clinical knowledge exchange, multidisciplinary collaboration and professional development. By strengthening these connections across the healthcare ecosystem, we can help support the responsible advancement of medical innovation and the continued development of patient-centered healthcare in Abu Dhabi.”

The MoU marks a step towards strengthening collaboration between healthcare providers in Abu Dhabi, with both organizations exploring opportunities to advance specialized care and support the evolving needs of patients.

For more information please visit our website : https://www.reemhospital.com/

The post Reem Hospital And Yas Clinic Sign MoU On Specialized Care, Regenerative Medicine And Cell Therapy In Abu Dhabi appeared first on Abu Dhabi Healthcare Guide.

Abu Dhabi is harnessing robotics and AI to advance fertility care and expand treatment options in the Emirate and beyond. Abu Dhabi-based ART Fertility Clinics, a member of IVI Institute, has signed a Memorandum of Understanding (MoU) with Conceivable Life Sciences, a New York-based medical technology company pioneering the application of robotics and physical artificial intelligence in in-vitro fertilisation (IVF), on the sidelines of Abu Dhabi Future Health Summit 2026.

The proposed collaboration will explore the introduction of Conceivable Life Sciences’ AURA platform at the IVI Institute in Abu Dhabi, covering site and workflow feasibility, training programmes for clinical and laboratory teams, and the validation and regulatory steps any future deployment would require.

In the presence of H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, the MoU was signed by Suresh Soni, Chief Executive Officer, ART Fertility Clinics, and Dr. Alejandro Chávez-Badiola, Chief Medical Officer and Co-Founder, Conceivable Life Sciences.

AURA is an automation-assisted platform that integrates Physical AI, robotics, advanced imaging, and software into IVF laboratory workflows. It is designed to perform key laboratory processes with greater precision and consistency under the supervision of embryologists.

The planned collaboration reflects ART Fertility Clinics’ commitment to combining clinical excellence with new technology to advance the future of reproductive medicine. The flagship IVI Institute in Abu Dhabi is envisioned as a destination for advanced fertility treatment, innovative laboratory capabilities and premium patient care, further strengthening Abu Dhabi’s position as a destination for healthcare innovation and international medical tourism.

H.E. Dr. Khuloud Al-Dhalei, Executive Director of the Healthcare Quality sector at DoH said: “Abu Dhabi is contributing to the future of reproductive health by exploring how robotics and AI can advance fertility care. This collaboration supports the responsible evaluation of technologies at the flagship IVI Institute, with the potential to improve precision and consistency in IVF laboratories, while maintaining specialist oversight and patient safety. Our aim is to translate innovation into better care for people seeking to build a family, in the Emirate and beyond.”

Suresh Soni, Chief Executive Officer, ART Fertility Clinics, said: “The IVI Institute is being built around a simple principle: patients deserve advanced fertility care, delivered by specialists they trust. Exploring AURA with Conceivable Life Sciences is a natural step in that direction. Automation has the potential to bring greater consistency to the IVF laboratory, while our embryologists and clinicians remain fully responsible for every clinical decision. We look forward to working together to understand how this technology can best serve patients in Abu Dhabi and across the region.”

Alan Murray, Chief Executive Officer and Co-Founder, Conceivable Life Sciences, said: “Abu Dhabi is fast becoming one of the world’s most forward-looking healthcare markets, and ART Fertility Clinics shares our belief that the IVF laboratory is ready for a new level of precision. AURA was built to bring robotics and Physical AI to some of the most delicate and repetitive steps in the laboratory workflow, under the supervision of embryologists. This MoU gives us a structured way to see how AURA fits ART’s laboratories and patients.”

Dr. Alejandro Chávez-Badiola, Co-Founder and Chief Medical and Innovation Officer, Conceivable Life Sciences, said: “As a fertility specialist, I have seen how much of IVF still depends on delicate manual steps performed under intense time pressure. AURA was developed to bring that work into a more controlled, standardised and traceable environment. Working with a clinical team of ART Fertility Clinics’ standing gives us the opportunity to explore how automation can support laboratory practice in the region.”

Abu Dhabi is advancing an integrated ecosystem that supports individuals and families throughout their reproductive health journey. Through the Abu Dhabi Programme for the Future of Reproductive Health, genetic screening programmes and the Global Reproductive Health Advisory Council, the Emirate is strengthening prevention, fertility care and research, translating innovation into better outcomes and reinforcing its position as a global capital for the future of reproductive health.

Abu Dhabi Future Health Summit (ADFHS) is the annual flagship gathering of Future Health – A Global Initiative by Abu Dhabi, a year-round platform for global collaboration curated and convened by the Department of Health – Abu Dhabi (DoH) together with the Founding Partners, PureHealth, M42, Institute for Healthier Living Abu Dhabi (IHLAD) and Mubadala BIO. Under the theme ‘To Sense Is to Predict’, ADFHS 2026 brings global experts and partners together to explore how earlier insight can support informed decisions, timely intervention and care better suited to people’s needs.

Four impact areas will guide the Summit’s discussions and initiatives: Longevity & Precision Health; Digital Health & AI; Health System Resilience & Sustainability; and Investment in Life Sciences. Together, they support Abu Dhabi’s ambition to turn earlier insight into earlier action and better care, helping people live longer, healthier lives.

For more information, visit Future Health – A Global Initiative by Abu Dhabi.

The post ART Fertility Clinics Signs Strategic MoU With Conceivable Life Sciences To Explore Automation-Assisted IVF Technology At IVI Institute appeared first on Abu Dhabi Healthcare Guide.

Schneider Electric and PureHealth have partnered to explore opportunities for advancing sustainability, digital innovation, and operational excellence across healthcare facilities and infrastructure.

Under the collaboration, Schneider Electric will provide PureHealth with access to its EcoStruxure™ Resource Advisor platform and also establish a framework for exploring sustainable infrastructure strategies, supporting the Group’s sustainability and energy management objectives across all facilities.

EcoStruxure™ Resource Advisor platform will support the management of Scope 1, Scope 2, and relevant Scope 3 emissions, enabling PureHealth to consolidate sustainability data across its portfolio and progress toward its science-based Net Zero 2040 target.

Through this platform, PureHealth will be able to enhance its long-term environmental and operational goals across three key areas: energy efficiency through advanced energy management; digital transformation and AI, including IoT-enabled monitoring, predictive maintenance, and ESG data management; and sustainability advisory, from sustainable building design and green building certifications to circular economy practices.

Olivier Blum, Chief Executive Officer, Schneider Electric, said, “By combining Schneider Electric’s expertise in electrification, digitalisation, automation, and sustainability with PureHealth’s leadership in healthcare, we look forward to exploring innovative solutions that can accelerate decarbonisation while enhancing operational performance across healthcare ecosystems.”

Shaista Asif, Group Chief Executive Officer of PureHealth, said, “By embedding sustainability into how healthcare environments are designed and operated, we can strengthen long-term performance while continuing to deliver better health outcomes for the communities we serve.”

The collaboration brings together Schneider Electric’s expertise in energy management, sustainability consulting, digital technologies, automation, and artificial intelligence with PureHealth’s extensive healthcare ecosystem spanning hospitals, clinics, laboratories, health technology, insurance, pharmacies, and procurement services across the region.

The partnership is aligned to the UAE’s climate agenda. The UAE has committed to net zero by 2050, with a 47 percent cut in greenhouse gas emissions by 2035 under its third Nationally Determined Contribution, and since May 2025 the UAE Climate Change Law has required all entities to measure, report, and reduce their emissions.

The partnership’s energy-efficiency and ESG data management work is intended to help PureHealth’s facilities respond to these requirements.

In Abu Dhabi, the partnership builds on targets already in place. The Department of Health – Abu Dhabi has put the emirate’s healthcare sector on a path to cut carbon emissions by 20 percent by 2030 and reach net zero by 2050, and PureHealth has committed to net zero by 2040, a target validated by the Science Based Targets initiative, after cutting its greenhouse gas emissions intensity by 37 percent between 2022 and 2024.

The collaboration underscores a shared commitment by both organisations to explore innovative solutions that support healthcare decarbonisation, accelerate digital transformation, and contribute to broader sustainability objectives across the UAE and the wider region.

The post Schneider Electric, PureHealth Partner To Accelerate Sustainable Healthcare Transformation appeared first on Abu Dhabi Healthcare Guide.

Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the UAE for serious and complex care and a subsidiary of PureHealth, the largest healthcare group in the Middle East, has been ranked among the world’s best hospitals for oncology in Newsweek’s World’s Best Specialized Hospitals 2027, placing second in the UAE and 219^th globally. This recognition underscores SSMC’s growing standing in specialised oncology care across the region and globally, and its commitment to delivering care in line with the highest international standards.

SSMC’s inclusion places its oncology services among the specialised hospitals recognised internationally by Newsweek and Statista, reflecting the strength of its integrated model for increasingly complex and personalised cancer care.

This achievement reflects the combined efforts of SSMC’s medical, nursing, technical and administrative teams, who work together to deliver comprehensive cancer care. It follows SSMC’s recent Magnet Recognition from the American Nurses Credentialing Center, which recognises nursing excellence and gives patients added confidence in the quality and safety of the care they receive. These recognitions underscore SSMC’s commitment to clinical excellence, an enhanced patient experience, and a culture that places each patient’s individual needs at the centre of every clinical decision.

SSMC brings together expertise across medical, surgical and radiation oncology, haematology, advanced imaging, molecular diagnostics and precision medicine within coordinated cancer pathways. Its capabilities span chemotherapy, immunotherapy and targeted therapies; advanced radiation therapy; PET and SPECT imaging; minimally invasive interventional oncology procedures including microwave ablation, cryoablation, TACE and TARE; genetic counselling; and multidisciplinary tumour boards. This integrated approach enables specialists to align diagnosis and treatment around the individual needs of patients, including those with complex and rare cancers.

Newsweek’s World’s Best Specialized Hospitals rankings are among the most recognised international benchmarks for healthcare institutions, highlighting clinical expertise and providing an independent measure of institutional standing regionally and globally. Developed in partnership with Statista, the rankings cover 13 medical fields and draw on international peer recognition, supported by hospital accreditations, certifications and centre designations.

Dr. Marwan Al Kaabi, Chief Executive Officer of SSMC, said: “Being ranked among the world’s best hospitals for oncology is an important recognition of the expertise our teams have built, and the model of cancer care we are advancing at SSMC. As cancer treatment becomes increasingly complex and personalised, patients need multidisciplinary expertise, precision medicine, advanced technology and research working together around their individual needs. We are providing this level of highly specialised care here in Abu Dhabi, giving patients and families from the UAE, the wider region and internationally greater choice when they need it most. By bringing world-class expertise and advanced treatment closer to home, we can help more patients access the right care while remaining closer to their families and support networks.”

SSMC’s oncology model is supported by its wider academic and research infrastructure, bringing clinical practice, education and research together. SSMC is Joint Commission International (JCI) -accredited and is the first hospital in the UAE to achieve JCI Academic Medical Center status, reflecting its integration of advanced clinical care with education and research.

Research is also embedded within SSMC’s approach to advancing patient care. Through its dedicated Clinical Trials Unit, SSMC conducts Phase I-IV and other clinical research, with current studies spanning oncology and haematology, including lung cancer, breast cancer, chronic myeloid leukaemia, lymphoma and multiple myeloma. Eligible patients may therefore have opportunities to participate in research evaluating emerging treatments and approaches, under established scientific and ethical protocols.

The recognition reinforces SSMC’s role in strengthening access to advanced oncology care within Abu Dhabi, while contributing to the emirate’s position as a destination for highly specialised healthcare.

The post Sheikh Shakhbout Medical City Ranked Among The World’s Best Hospitals For Oncology In Newsweek’s 2027 Rankings appeared first on Abu Dhabi Healthcare Guide.